Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-10-27
1978-10-10
Hines, Robert V.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
2603405R, 2603437, 26050117, 26050118, 26050119, 424280, 424282, 424316, A01N 920
Patent
active
041197291
ABSTRACT:
A new class of phenoxypropanolamine alkylsulfonyl derivatives and methods for their preparation are described. The new compounds possess antiarrhythmic and/or cardioselective .beta.-adrenergic blocking properties and are useful in the treatment of hypertension. Representative embodiments of the invention are 1-(isopropylamino)-3-[4-(methylsulfonyl)-m-tolyloxy]-2-propanol and 3-[4-(methylsulfonyl)-m-tolyloxy]-1-(1-phenoxy-2-propylamino)-2-propanol, the latter compound is particularly outstanding as an antihypertensive.
REFERENCES:
patent: 3375256 (1968-03-01), Bach et al.
patent: 3501769 (1970-03-01), Crowther et al.
patent: 3627832 (1971-12-01), Schulenberg et al.
patent: 3631108 (1971-12-01), Brandstrom et al.
patent: 3732308 (1973-05-01), Lauria et al.
patent: 4067904 (1978-01-01), Comer et al.
Derivent Abstracts, "Basic No. 41,107", pp. 357-366 (1969).
Burger, "Medicinal Chemistry" 3rd Ed., p. 77 (1970).
Comer William T.
Kreighbaum William E.
Carnahan Robert E.
Hines Robert V.
Mead Johnson & Company
Uloth Robert H.
LandOfFree
Alkylsulfonylphenoxypropanolamine therapeutic process does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkylsulfonylphenoxypropanolamine therapeutic process, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkylsulfonylphenoxypropanolamine therapeutic process will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1767219